Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASTIC trial in Crohn's disease
2005-003337-40Phase 3Unknown
- Sponsor
- EBMT
- Start
- Jan 2006
- Modality
- Small Molecules, Cytokines & Interferons → Recombinant Proteins and Enzymes, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of cyclophosphamide, filgrastim and antithymocyte globulin rabbit in Crohn's disease (2 arms), sponsored by EBMT. Status: unknown.
02
Drugs
cyclophosphamidefilgrastimantithymocyte globulin rabbit
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2005-003337-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003337-40.